Advanced mutant receptor activator of nuclear factor kappa‐Β ligand development with low affinity for osteoprotegerin
Saved in:
Main Authors: | Yuria Jang, Yongjin Cho, Youngjong Ko, Yeonhee Moon, Chang‐Moon Lee, Wonbong Lim |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Clinical and Translational Medicine |
Online Access: | https://doi.org/10.1002/ctm2.70195 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Osteoprotegerin, Soluble Receptor Activator of Nuclear Factor-κB Ligand, and Subclinical Atherosclerosis in Children and Adolescents with Type 1 Diabetes Mellitus
by: Irene Lambrinoudaki, et al.
Published: (2013-01-01) -
Osteoprotegerin in Cardiometabolic Disorders
by: C. Pérez de Ciriza, et al.
Published: (2015-01-01) -
Mutant glycosidases for labeling sialoglycans with high specificity and affinity
by: Shuyu Liang, et al.
Published: (2025-02-01) -
Inhibitors of nuclear factor kappa B cause apoptosis in cultured macrophages
by: E. E. Mannick, et al.
Published: (1997-01-01) -
Scutellarin Attenuates Hypertension-Induced Expression of Brain Toll-Like Receptor 4/Nuclear Factor Kappa B
by: Xingyong Chen, et al.
Published: (2013-01-01)